Skip to main content
. 2020 Dec 23;11(1):16. doi: 10.3390/nano11010016

Figure 9.

Figure 9

Cumulative doxorubicin percentage release profiles from the hydrogel and gels containing citrate-stabilized (CS) and lipid-coated (LC) nanoparticles (0.1 wt%) (A) without an externally applied alternating magnetic field (AMF) and (B) comparison of the magnetogels release when an AMF is applied for 30, 60, and 90 min between t = 4 h and t = 6 h. (C) Cumulative doxorubicin released at t = 6 h. (D) Variation of doxorubicin percentage released between t=4 h and t = 6 h, that is, for a period of 2 h.